8-K: Health Catalyst Holds Annual Meeting, Elects Directors and Ratifies Auditor

Sentiment:

Annual Meeting Results


Health Catalyst held its annual meeting on June 13, 2024, where stockholders elected three directors, ratified the appointment of Ernst & Young LLP as the independent auditor, and approved executive compensation.

Summary

  • Health Catalyst held its annual meeting of stockholders on June 13, 2024.
  • Three directors, Daniel Burton, John A. Kane, and Julie Larson-Green, were elected to serve as Class II directors for a three-year term expiring at the 2027 annual meeting.
  • The appointment of Ernst & Young LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2024, was ratified.
  • An advisory, non-binding vote to approve the compensation of the company's named executive officers was also approved by stockholders.
  • A total of 59,033,536 shares were entitled to vote, and 49,177,309 shares were present or represented by proxy at the meeting.

Sentiment

Score: 7

Explanation: The document reflects standard corporate governance procedures, indicating a stable and well-managed company. There are no indications of any issues or concerns.

Positives

  • The election of directors ensures continuity and stability in the company's leadership.
  • The ratification of Ernst & Young LLP as the auditor provides confidence in the company's financial reporting.
  • The approval of executive compensation indicates shareholder support for the company's management team.

Industry Context

This announcement is a routine corporate governance event for a publicly traded company, ensuring compliance with regulatory requirements and shareholder engagement.

Comparison to Industry Standards

  • The election of directors and ratification of auditors are standard practices for publicly listed companies like Health Catalyst.
  • The voting results are typical for annual meetings, with most proposals receiving majority support.
  • Companies such as Cerner (now Oracle Health) and Allscripts also conduct similar annual meetings to ensure corporate governance.

Stakeholder Impact

  • Shareholders have exercised their voting rights on key governance matters.
  • The election of directors and ratification of the auditor provide assurance to stakeholders about the company's oversight and financial integrity.

Key Dates

DateDescription
April 29, 2024Date the company's definitive proxy statement was filed with the SEC.
June 13, 2024Date of the Health Catalyst annual meeting of stockholders.
June 17, 2024Date the 8-K report was signed.
December 31, 2024End of the fiscal year for which Ernst & Young LLP will perform the audit.
2027Year the newly elected directors' terms expire.

Keywords

Annual Meeting, Director Election, Auditor Ratification, Executive Compensation, Shareholder Vote, Corporate Governance

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.